Agenda

5 mins Welcome and Introductions
45 mins BRCA and Beyond – Clinical Focus on the DNA Damage Response Pathway
Advancing Therapeutic Paradigms – Examining the Role of PARP Inhibitors in Ovarian Cancer
Translating Tumor Sequencing into Clinical Decision Making – Practical Strategies for the Oncology Clinician
Integrating PARP Inhibitors into Practice – Expert Answers to Top Clinical Questions
10 mins Wrap-Up and Q&A

Target Audience

Gynecologic oncologists and the ovarian cancer care team.